Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: A multicentric, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: A multicentric, double-blind, placebo-controlled trial

Published:2007-07 Issue:1-3 Volume:93 Page:99-108
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Baptista Trino,Rangel Nairy,Fernández Virginia,Carrizo Edgardo,El Fakih Yamily,Uzcátegui Euderruh,Galeazzi Tatiana,Gutiérrez María A.,Servigna Mercedes,Dávila Adriana,Uzcátegui Marycelvia,Serrano Ana,Connell Lisette,Beaulieu Serge,de Baptista Enma Araujo

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference38 articles.

1. Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine;Assuncao;Rev. Bras. Psiquiatr.,2006

2. Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs?;Baptista;Can. J. Psychiatry,2002

3. Metformin in the obesity associated to antipsychotic drug-administration: a pilot study;Baptista;J. Clin. Psychiatry,2001

4. Treatment of the metabolic disturbances caused by antipsychotic drugs;Baptista;Clin. Pharmacokinet.,2004

5. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial;Baptista;Can. J. Psychiatry,2006

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological interventions for antipsychotic-induced weight gain in schizophrenia: A network meta-analysis;General Hospital Psychiatry;2024-09

2. The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression;Frontiers in Psychiatry;2023-07-12

3. Are the antidepressant effects of insulin-sensitizing medications related to improvements in metabolic markers?;Translational Psychiatry;2022-11-08

4. Metformin ameliorates olanzapine-induced obesity and glucose intolerance by regulating hypothalamic inflammation and microglial activation in female mice;Frontiers in Pharmacology;2022-10-12

5. Pharmacological interventions for prevention of weight gain in people with schizophrenia;Cochrane Database of Systematic Reviews;2022-10-03